Tazicef - 0409-5082-16 - (CEFTAZIDIME)

Alphabetical Index


Drug Information of Tazicef

Product NDC: 0409-5082
Proprietary Name: Tazicef
Non Proprietary Name: CEFTAZIDIME
Active Ingredient(s): 1    g/1 & nbsp;   CEFTAZIDIME
Administration Route(s): INTRAMUSCULAR; INTRAVENOUS
Dosage Form(s): INJECTION, POWDER, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Tazicef

Product NDC: 0409-5082
Labeler Name: Hospira, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA062662
Marketing Category: ANDA
Start Marketing Date: 20120305

Package Information of Tazicef

Package NDC: 0409-5082-16
Package Description: 25 VIAL in 1 TRAY (0409-5082-16) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL

NDC Information of Tazicef

NDC Code 0409-5082-16
Proprietary Name Tazicef
Package Description 25 VIAL in 1 TRAY (0409-5082-16) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL
Product NDC 0409-5082
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name CEFTAZIDIME
Dosage Form Name INJECTION, POWDER, FOR SOLUTION
Route Name INTRAMUSCULAR; INTRAVENOUS
Start Marketing Date 20120305
Marketing Category Name ANDA
Labeler Name Hospira, Inc.
Substance Name CEFTAZIDIME
Strength Number 1
Strength Unit g/1
Pharmaceutical Classes Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient]

Complete Information of Tazicef


General Information